Earnings
AYURCANN REPORTS Q1 2026 SALES OF $14,638,697

AYUR · Price
Executive Summary
- Ayurcann Holdings Corp. reported Q1 2026 interim results, posting CAD 14.64 million in gross revenue and a gross profit of CAD 2.24 million, yielding a 26% gross margin.
- The company highlighted its position as a top‑3 vape producer in Ontario with a 5% share of the national vape market and a 7% share within Ontario.
- Over the past six months, Ayurcann launched 30 new SKUs across vapes, pre‑rolls, and concentrates, underscoring accelerated product innovation.
Key Details
- Revenue: CAD 14,638,697 (Q1 2026) vs. CAD 14,657,485 (Q1 2025).
- Gross Profit: CAD 2,236,343 (Q1 2026) vs. CAD 3,321,974 (Q1 2025).
- Gross Margin: 26% in Q1 2026, down from 40% in Q1 2025.
- Market Position: Ranked among the top three vape producers in Ontario; holds ~5% of Canada’s total vape market and ~7% share in Ontario (source: Hifyre IQTM).
- Product Expansion: Introduced 30 new SKUs across vapes, pre‑rolls, and concentrates within the last six months.
- Operational Highlights: Emphasized efficient manufacturing, strong output quality, and on‑time execution.
- Growth Strategy: Scaling aggressively into high‑demand pre‑rolls and concentrates; expanding distribution through licensed Canadian retail stores.
Notable Quotes
(No direct quotes were provided in the release.)